NEWSROOM
HOLIDAY ISLAND HOLDINGS, INC. HAS FINALIZED FUNDING FOR ITS WINDY POINT OIL EXTRACTION DEVELOPMENT
Plant City, Florida, June 17, 2024 - Holiday Island Holdings, Inc. (OTC: HIHI), (soon to be EP3Oil, Inc.), has finalized a $525,000 development in Windy Point through equity investments and strategic partnerships. This rich project is a joint venture with Cavalier Oil in central Texas. It has been drilled, and the test results are promising. The development could start production in as few as two months. Windy Point offers as many as ten wells in an aggressive expansion program. Depending on...
Formation Minerals, Inc. Announces Corporate Update
JACKSBORO, Texas, June 13, 2024 -- Formation Minerals, Inc. (OTCQB: FOMI) (“Formation” or the “Company”), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and royalties, today provided an update on the Company’s activities following the closing of its acquisition of Verde Bio Holdings, Inc. (“Verde”) on May 9, 2024 to create a premier company focused on the acquisition and management of oil and gas minerals and royalties and its business...
Rodedawg (OTC: RWGI) Launches TikTok Shop to Expand into Global E-Commerce Market
Company E-commerce Effort Expands into 10 Billion Dollar Marketplace COSTA MESA, CA, June 12th, 2024 – Rodedawg International Industries, Inc. (OTC: RWGI), a prominent cannabis manufacturer and distributor, is excited to announce the launch of its own TikTok Shop. This strategic move aims to leverage the booming e-commerce potential on TikTok, expanding Rodedawg's market reach and driving sales of its popular product lines. The initial product offering is the All natural Elixicure Topical Pain...
SIPP Industries Announces Strategic R&D Agreement with Calypso Pharmaceuticals to Develop Nano-Emulsified Topical Targeting Melanoma
Costa Mesa, CA, June 11, 2024 - SIPP Industries, Inc. (OTC: SIPC), a multifaceted corporation specializing in the manufacturing and distribution of commercial and consumer products in the cannabis industry, is pleased to announce a Research and Development agreement with Calypso Pharmaceuticals. The aim is to create a nano-emulsified topical formulation in collaboration with AVEINA, SIPP's wellness-focused brand specializing in nanotechnology formulations, to target melanoma using Peptide...
SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia
Fort Lauderdale, FL., June 11, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announced that its SSi Mantra Surgical Robotic System has received regulatory approval from the Indonesian Ministry of Health for clinical use in the Republic of Indonesia. With more than 279 million people,...
GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Extension of Agreement with PeaceHealth Sacred Heart Medical Center at RiverBend
Extended 10-year Agreement to Upgrade Gamma Knife® Perfexion™ with Elekta Esprit San Francisco, CA, June 7, 2024 – GK Financing LLC (GKF), a subsidiary of American Shared Hospital Services (NYSE American: AMS), a leading provider of turnkey technology solutions for advanced radiosurgery and radiation oncology services, announced today that it has extended its current agreement with PeaceHealth Sacred Heart Medical Center at RiverBend in Springfield, Ore. The new agreement will see the center...
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study
New York, June 3, 2024—Oncocyte’s (Nasdaq: OCX) VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial, published in the prestigious New England Journal of Medicine. The trial evaluated the test's effectiveness in monitoring graft health in patients with antibody-mediated rejection (AMR), a leading cause of kidney transplant failure. The study's positive outcomes highlight new clinical uses for VitaGraft Kidney, including therapeutic...
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
Clinical testing of LP-310 expected to commence in mid-2024 Patient recruitment is underway for Phase 2a multicenter, dose-ranging study PITTSBURGH, PA., May 31, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced the successful completion of its first Site Initiation Visit (SIV) for the Phase 2a trial evaluating LP-310 in the treatment...
SS Innovations Engages BDO as its new Auditor
SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company’s commitment to transparent financial and accounting practices and regulatory compliance FORT LAUDERDALE, Fla., May 31, 2024 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to...
AmpliTech Announces Receipt of Notice from Nasdaq Regaining Compliance
Hauppauge, NY, May 30, 2024 - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks, including the design of complete 5G/6G systems, and a global distributor of packages and lids for integrated circuit assembly, announced today that it received a notice from the Nasdaq Stock Market, stating the Company has regained compliance with Nasdaq’s periodic filing...